Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release
NDC Package 49035-488-69
Package Information
Loratadine And Pseudoephedrine Sulfate tablets is do not divide, crush, chew or dissolve the tabletadults and children 12 years and over1 tablet daily with a full glass of water; not more than 1 tablet in 24 hourschildren under 12 years of ageask a doctorconsumers with liver or kidney diseaseask a doctor. This formulation utilizes a tablet, extended release delivery system. Marketed by Wal-mart Stores, Inc, this product is identified by NDC 49035-488 and is authorized under FDA application ANDA076557.
Identification & Billing
- RxCUI: 1117562 - pseudoephedrine sulfate 240 MG / loratadine 10 MG 24HR Extended Release Oral Tablet
- RxCUI: 1117562 - 24 HR loratadine 10 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet
- RxCUI: 1117562 - loratadine 10 MG / pseudoephedrine sulfate 240 MG 24 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49035 - Wal-mart Stores, Inc
- 49035-488 - Loratadine And Pseudoephedrine Sulfate
- 49035-488-69 - 10 TABLET, EXTENDED RELEASE in 1 CARTON
- 49035-488 - Loratadine And Pseudoephedrine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (49035-488). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49035-488-69 identifies a specific commercial package of 10 tablet, extended release in 1 carton of Loratadine And Pseudoephedrine Sulfate, a human over the counter drug labeled by Wal-mart Stores, Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This tablet, extended release is formulated for oral use and contains loratadine; pseudoephedrine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wal-mart Stores, Inc on June 15, 2020. The current certification is valid through December 31, 2026.
How is this Wal-mart Stores, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49035048869. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.